0.012359 0.007136 0.000000 0.000000 0.014271 0.000000 0.000000 0.000000 0.030084 0.000000 0.000000 0.000000 Favero-Retto, M.P. Palmieri, L.C. Lima, L.M.T.R. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 18 90.000 90.000 120.000 80.910 80.910 33.240 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking Cl -1 35.453 CHLORIDE ION non-polymer C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking Zn 2 65.409 ZINC ION non-polymer NE Eur J Pharm Biopharm 0353 0939-6411 85 1112 1121 10.1016/j.ejpb.2013.05.005 23692694 Structural meta-analysis of regular human insulin in pharmaceutical formulations. 2013 100 1 CCD MAR CCD 165 mm Si(111) SINGLE WAVELENGTH M x-ray 1 1.0 D03B-MX1 LNLS SYNCHROTRON LNLS BEAMLINE D03B-MX1 2383.698 Insulin A chain UNP residues 90-110 2 nat polymer 3433.953 Insulin B chain UNP residues 25-54 2 nat polymer 65.409 ZINC ION 2 syn non-polymer 35.453 CHLORIDE ION 2 syn non-polymer 18.015 water 98 nat water no no GIVEQCCTSICSLYQLENYCN GIVEQCCTSICSLYQLENYCN A,C polypeptide(L) no no FVNQHLCGSHLVEALYLVCGERGFFYTPKT FVNQHLCGSHLVEALYLVCGERGFFYTPKT B,D polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample 9606 Homo sapiens human sample 9606 Homo sapiens 1 1.80 31.65 VAPOR DIFFUSION, HANGING DROP 5.5 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000, cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K 293 software repository Initial release Database references Database references Refinement description 1 0 2013-05-01 1 1 2013-06-12 1 2 2013-12-18 1 3 2017-11-15 _software.name RCSB Y RCSB 2012-04-28 REL REL ZN ZINC ION CL CHLORIDE ION HOH water ZN 2 3 ZN ZN 101 B CL 1 4 CL CL 102 B ZN 1 3 ZN ZN 101 D CL 1 4 CL CL 102 D HOH 144 5 HOH HOH 101 A HOH 154 5 HOH HOH 102 A HOH 159 5 HOH HOH 103 A HOH 160 5 HOH HOH 104 A HOH 163 5 HOH HOH 105 A HOH 183 5 HOH HOH 106 A HOH 184 5 HOH HOH 107 A HOH 186 5 HOH HOH 108 A HOH 192 5 HOH HOH 109 A HOH 202 5 HOH HOH 110 A HOH 204 5 HOH HOH 111 A HOH 205 5 HOH HOH 112 A HOH 208 5 HOH HOH 113 A HOH 210 5 HOH HOH 114 A HOH 218 5 HOH HOH 115 A HOH 221 5 HOH HOH 116 A HOH 244 5 HOH HOH 117 A HOH 252 5 HOH HOH 118 A HOH 255 5 HOH HOH 119 A HOH 259 5 HOH HOH 120 A HOH 260 5 HOH HOH 121 A HOH 131 5 HOH HOH 201 B HOH 132 5 HOH HOH 202 B HOH 135 5 HOH HOH 203 B HOH 141 5 HOH HOH 204 B HOH 142 5 HOH HOH 205 B HOH 148 5 HOH HOH 206 B HOH 149 5 HOH HOH 207 B HOH 150 5 HOH HOH 208 B HOH 151 5 HOH HOH 209 B HOH 155 5 HOH HOH 210 B HOH 162 5 HOH HOH 211 B HOH 164 5 HOH HOH 212 B HOH 165 5 HOH HOH 213 B HOH 169 5 HOH HOH 214 B HOH 170 5 HOH HOH 215 B HOH 173 5 HOH HOH 216 B HOH 175 5 HOH HOH 217 B HOH 185 5 HOH HOH 218 B HOH 188 5 HOH HOH 219 B HOH 206 5 HOH HOH 220 B HOH 209 5 HOH HOH 221 B HOH 215 5 HOH HOH 222 B HOH 219 5 HOH HOH 223 B HOH 222 5 HOH HOH 224 B HOH 236 5 HOH HOH 225 B HOH 239 5 HOH HOH 226 B HOH 240 5 HOH HOH 227 B HOH 245 5 HOH HOH 228 B HOH 248 5 HOH HOH 229 B HOH 251 5 HOH HOH 230 B HOH 253 5 HOH HOH 231 B HOH 256 5 HOH HOH 232 B HOH 257 5 HOH HOH 233 B HOH 137 5 HOH HOH 101 C HOH 140 5 HOH HOH 102 C HOH 143 5 HOH HOH 103 C HOH 145 5 HOH HOH 104 C HOH 167 5 HOH HOH 105 C HOH 174 5 HOH HOH 106 C HOH 190 5 HOH HOH 107 C HOH 191 5 HOH HOH 108 C HOH 197 5 HOH HOH 109 C HOH 201 5 HOH HOH 110 C HOH 203 5 HOH HOH 111 C HOH 229 5 HOH HOH 112 C HOH 230 5 HOH HOH 113 C HOH 254 5 HOH HOH 114 C HOH 2 5 HOH HOH 201 D HOH 4 5 HOH HOH 202 D HOH 72 5 HOH HOH 203 D HOH 136 5 HOH HOH 204 D HOH 138 5 HOH HOH 205 D HOH 139 5 HOH HOH 206 D HOH 146 5 HOH HOH 207 D HOH 147 5 HOH HOH 208 D HOH 152 5 HOH HOH 209 D HOH 156 5 HOH HOH 210 D HOH 157 5 HOH HOH 211 D HOH 158 5 HOH HOH 212 D HOH 161 5 HOH HOH 213 D HOH 166 5 HOH HOH 214 D HOH 168 5 HOH HOH 215 D HOH 171 5 HOH HOH 216 D HOH 176 5 HOH HOH 217 D HOH 179 5 HOH HOH 218 D HOH 194 5 HOH HOH 219 D HOH 198 5 HOH HOH 220 D HOH 200 5 HOH HOH 221 D HOH 211 5 HOH HOH 222 D HOH 216 5 HOH HOH 223 D HOH 224 5 HOH HOH 224 D HOH 226 5 HOH HOH 225 D HOH 235 5 HOH HOH 226 D HOH 238 5 HOH HOH 227 D HOH 246 5 HOH HOH 228 D HOH 250 5 HOH HOH 229 D HOH 258 5 HOH HOH 230 D 39.000 2.500 2.500 20.710 20.710 Phaser MODE: MR_AUTO GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A PHE 1 n 1 PHE 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B HIS 10 n 10 HIS 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B THR 27 n 27 THR 27 B PRO 28 n 28 PRO 28 B LYS 29 n 29 LYS 29 B THR 30 n 30 THR 30 B GLY 1 n 1 GLY 1 C ILE 2 n 2 ILE 2 C VAL 3 n 3 VAL 3 C GLU 4 n 4 GLU 4 C GLN 5 n 5 GLN 5 C CYS 6 n 6 CYS 6 C CYS 7 n 7 CYS 7 C THR 8 n 8 THR 8 C SER 9 n 9 SER 9 C ILE 10 n 10 ILE 10 C CYS 11 n 11 CYS 11 C SER 12 n 12 SER 12 C LEU 13 n 13 LEU 13 C TYR 14 n 14 TYR 14 C GLN 15 n 15 GLN 15 C LEU 16 n 16 LEU 16 C GLU 17 n 17 GLU 17 C ASN 18 n 18 ASN 18 C TYR 19 n 19 TYR 19 C CYS 20 n 20 CYS 20 C ASN 21 n 21 ASN 21 C PHE 1 n 1 PHE 1 D VAL 2 n 2 VAL 2 D ASN 3 n 3 ASN 3 D GLN 4 n 4 GLN 4 D HIS 5 n 5 HIS 5 D LEU 6 n 6 LEU 6 D CYS 7 n 7 CYS 7 D GLY 8 n 8 GLY 8 D SER 9 n 9 SER 9 D HIS 10 n 10 HIS 10 D LEU 11 n 11 LEU 11 D VAL 12 n 12 VAL 12 D GLU 13 n 13 GLU 13 D ALA 14 n 14 ALA 14 D LEU 15 n 15 LEU 15 D TYR 16 n 16 TYR 16 D LEU 17 n 17 LEU 17 D VAL 18 n 18 VAL 18 D CYS 19 n 19 CYS 19 D GLY 20 n 20 GLY 20 D GLU 21 n 21 GLU 21 D ARG 22 n 22 ARG 22 D GLY 23 n 23 GLY 23 D PHE 24 n 24 PHE 24 D PHE 25 n 25 PHE 25 D TYR 26 n 26 TYR 26 D THR 27 n 27 THR 27 D PRO 28 n 28 PRO 28 D LYS 29 n 29 LYS 29 D THR 30 n 30 THR 30 D author_and_software_defined_assembly PISA 12 dodecameric 21280 -376 10850 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -0.5000000000 -0.8660254038 0.0000000000 0.8660254038 -0.5000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 2_555 -y,x-y,z crystal symmetry operation 0.0000000000 0.0000000000 0.0000000000 -0.5000000000 0.8660254038 0.0000000000 -0.8660254038 -0.5000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 3_555 -x+y,-x,z crystal symmetry operation 0.0000000000 0.0000000000 0.0000000000 A N CYS 11 A N CYS 11 B O GLN 4 B O GLN 4 B N TYR 26 B N TYR 26 D O PHE 24 D O PHE 24 1 B ZN 101 E ZN 1 B CL 102 F CL 1 D ZN 101 G ZN 1 B HOH 227 J HOH 1 C C ILE CYS 10 11 -147.88 1 C SER 9 A -115.78 -117.12 1 C SER 9 B -116.16 -126.36 55.640 14.1289 3.220 0.0700 0.0400 0.0000 0.0700 0.0000 -0.1100 0.9080 0.8160 HYDROGENS HAVE BEEN USED IF PRESENT IN THE INPUT U VALUES : REFINED INDIVIDUALLY 0.2875 0.2007 0.2086 2.300 40.45 330 3606 9.2 99.78 1.000 0.330 10.2200 0.2560 RANDOM 1 THROUGHOUT 0.0 MOLECULAR REPLACEMENT 0.7770 0.3720 0.8000 0.8000 1.2000 MAXIMUM LIKELIHOOD BABINET MODEL WITH MASK 2.300 40.45 98 910 4 0 808 0.014 0.020 894 1.655 1.947 1224 9.017 5.000 111 37.796 24.048 42 18.288 15.000 140 18.080 15.000 3 0.105 0.200 135 0.006 0.021 696 0.2480 0.1800 2.360 19 257 276 20 100.0 2.300 40.455 4EWW 3608 3608 0.093 1 9.4 3.0 99.8 0.170 2.300 2.420 4.40 1590 530 0.170 1 3.0 100.0 0.143 2.420 2.570 4.90 1535 509 0.143 1 3.0 100.0 0.153 2.570 2.750 4.10 1374 457 0.153 1 3.0 100.0 0.086 2.750 2.970 8.10 1321 437 0.086 1 3.0 100.0 0.063 2.970 3.250 11.10 1243 410 0.063 1 3.0 100.0 0.124 3.250 3.640 3.50 1070 363 0.124 1 2.9 100.0 0.099 3.640 4.200 4.20 944 313 0.099 1 3.0 100.0 0.040 4.200 5.140 14.90 829 272 0.040 1 3.0 100.0 0.040 5.140 7.270 17.40 651 211 0.040 1 3.1 100.0 0.031 7.270 20.227 19.70 331 106 0.031 1 3.1 94.5 data reduction Andrew G.W. Leslie andrew@mrc-lmb.cam.ac.uk http://www.mrc-lmb.cam.ac.uk/harry/mosflm/ MOSFLM package data scaling Phil R. Evans pre@mrc-lmb.cam.ac.uk 2011/05/18 Fortran_77 http://www.ccp4.ac.uk/dist/html/scala.html SCALA other 3.3.20 phasing Randy J. Read cimr-phaser@lists.cam.ac.uk Wed Jun 24 14:00:05 2009 http://www-structmed.cimr.cam.ac.uk/phaser/ PHASER program 2.1.4 refinement Garib N. Murshudov garib@ysbl.york.ac.uk Fortran_77 http://www.ccp4.ac.uk/dist/html/refmac5.html REFMAC program 5.6.0117 data extraction PDB deposit@deposit.rcsb.org April 22, 2011 C++ http://sw-tools.pdb.org/apps/PDB_EXTRACT/ PDB_EXTRACT package 3.11 data collection MAR345 Insulin A chain, Insulin B chain Human Insulin 1 N N 2 N N 1 N N 2 N N 3 N N 4 N N 3 N N 4 N N 5 N N 5 N N 5 N N 5 N N A GLY 1 A GLY 1 HELX_P A CYS 7 A CYS 7 1 1 7 A LEU 13 A LEU 13 HELX_P A GLU 17 A GLU 17 1 2 5 A ASN 18 A ASN 18 HELX_P A CYS 20 A CYS 20 5 3 3 B GLY 8 B GLY 8 HELX_P B GLY 20 B GLY 20 1 4 13 B GLU 21 B GLU 21 HELX_P B GLY 23 B GLY 23 5 5 3 C ILE 2 C ILE 2 HELX_P C SER 9 C SER 9 1 6 8 C SER 12 C SER 12 HELX_P C GLU 17 C GLU 17 1 7 6 C ASN 18 C ASN 18 HELX_P C CYS 20 C CYS 20 5 8 3 D GLY 8 D GLY 8 HELX_P D GLY 20 D GLY 20 1 9 13 D GLU 21 D GLU 21 HELX_P D GLY 23 D GLY 23 5 10 3 disulf 2.049 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.029 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 2.025 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 disulf 2.001 C CYS 6 C SG CYS 6 1_555 C CYS 11 C SG CYS 11 1_555 disulf 2.027 C CYS 7 C SG CYS 7 1_555 D CYS 7 D SG CYS 7 1_555 disulf 2.084 C CYS 20 C SG CYS 20 1_555 D CYS 19 D SG CYS 19 1_555 metalc 2.014 D HIS 10 D NE2 HIS 10 1_555 D ZN 101 G ZN ZN 1_555 metalc 2.131 B HIS 10 B NE2 HIS 10 1_555 B ZN 101 E ZN ZN 1_555 HORMONE HORMONE INS_HUMAN UNP 1 90 P01308 GIVEQCCTSICSLYQLENYCN INS_HUMAN UNP 2 25 P01308 FVNQHLCGSHLVEALYLVCGERGFFYTPKT 90 110 4EWW 1 21 P01308 A 1 1 21 25 54 4EWW 1 30 P01308 B 2 1 30 90 110 4EWW 1 21 P01308 C 1 1 21 25 54 4EWW 1 30 P01308 D 2 1 30 2 2 anti-parallel anti-parallel A CYS 11 A CYS 11 A SER 12 A SER 12 B ASN 3 B ASN 3 B GLN 4 B GLN 4 B PHE 24 B PHE 24 B TYR 26 B TYR 26 D PHE 24 D PHE 24 D TYR 26 D TYR 26 BINDING SITE FOR RESIDUE ZN B 101 Software 6 BINDING SITE FOR RESIDUE CL B 102 Software 3 BINDING SITE FOR RESIDUE ZN D 101 Software 6 BINDING SITE FOR RESIDUE CL D 102 Software 5 B HIS 10 B HIS 10 6 2_555 B HIS 10 B HIS 10 6 3_555 B HIS 10 B HIS 10 6 1_555 B CL 102 F CL 6 2_555 B CL 102 F CL 6 3_555 B CL 102 F CL 6 1_555 B ZN 101 E ZN 3 1_555 B ZN 101 E ZN 3 2_555 B ZN 101 E ZN 3 3_555 D HIS 10 D HIS 10 6 3_555 D HIS 10 D HIS 10 6 2_555 D HIS 10 D HIS 10 6 1_555 D CL 102 H CL 6 3_555 D CL 102 H CL 6 2_555 D CL 102 H CL 6 1_555 D ZN 101 G ZN 5 1_555 D ZN 101 G ZN 5 2_555 D ZN 101 G ZN 5 3_555 D HOH 226 L HOH 5 1_555 D HOH 226 L HOH 5 2_555 146 H 3